Operations Update and Initiation of Arbitration

Written by Customer Service on December 24, 2022. Posted in Public Companies.

CALGARY, Alberta, Dec. 24, 2022 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura”) is pleased to announce today that repair and testing of the Zarghun South sale gas pipeline, which was damaged due to flash floods, have been completed and the supply of sale gas has resumed from the Zarghun South Lease. The Zarghun South Lease covers an area of 124.22 square kilometers in the western part of the Sulaiman Fold and Thrust Belt of the Middle Indus Basin. It is strategically located near the gas demand centre of the city of Quetta. Jura holds a 40% working interest in the Zarghun South Lease, which is operated by Mari Petroleum Company Limited. Jura also provides an update with regard to a dispute between its wholly-owned subsidiaries, Spud Energy Pty Limited (“SEPL”) and Frontier Holdings Limited (“FHL”), with Petroleum Exploration...

LPI Completes Maricunga Ownership Consolidation

Written by Customer Service on December 24, 2022. Posted in Mergers And Acquisitions.

HIGHLIGHTS LPI has now completed the Bearing Transaction to acquire the final 17.14% interest in Maricunga LPI has now consolidated ownership of 100% of Maricunga SYDNEY, Australia, Dec. 24, 2022 (GLOBE NEWSWIRE) — Lithium Power International Limited (ASX: LPI) (“LPI” or the “Company”) is pleased to advise that it has now successfully completed the Plan of Arrangement with joint venture partner Bearing Lithium Corp. (BRZ:TSXV) (“Bearing Transaction”) who held a 17.14% interest in the Maricunga lithium brine project in Chile (“Maricunga”). As announced on 20 December, the Company completed the merger with Salar Blanco, LLC to acquire the 31.31% of Maricunga which was held by joint venture partner Minera Salar Blanco SpA (“SBD Transaction”) (together with the Bearing Transaction, the “Transactions”). As a result of the Transactions...

Correction: Awilco Drilling PLC: Mandatory notification of trade – primary insiders

Written by Customer Service on December 24, 2022. Posted in Public Companies.

Reference is made to the stock exchange announcement by Awilco Drilling PLC (the “Company”) published on 21 December 2022, regarding the successful private placement of new Sponsored Norwegian Depository Receipts in the Company (the “Private Placement”). Certain of the Company’s primary insiders and their close associates have subscribed and been allocated new Sponsored Norwegian Depository Receipts in the Private Placement as further described in the attached forms. Aberdeen, 24 December 2022 For further information please contact: Erik Jacobs, CEO of Awilco Drilling; Tel: +44 1224 737900Cathrine Haavind, Investor Relations of Awilco Drilling; Tel: +47 93 42 84 64, ch@awilcodrilling.com This information is subject to the disclosure requirements in Article 19 of MAR (Regulation (EU) No. 596/2014 on market...

Coherus and Junshi Biosciences Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Written by Customer Service on December 24, 2022. Posted in Public Companies.

– FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA – – Coherus and Junshi Biosciences are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the U.S. as quickly as possible – SHANGHAI, China, and REDWOOD CITY, Calif., Dec. 24, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced that the companies have not received an action letter from the U.S. Food and Drug Administration (FDA, the Agency) regarding the Biologics License Application (BLA) for toripalimab in combination with chemotherapy as treatment for recurrent or metastatic...

PlantX Announces Filing of Restated Financial Statements for the Year Ended March 31, 2021 and Filing of the Annual Financial Statements for the Year Ended March 31, 2022

Written by Customer Service on December 24, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Dec. 23, 2022 (GLOBE NEWSWIRE) — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company“), the digital face of the plant-based community, operating a one-stop shop for plant-based products, announces the filing of its restated audited consolidated comparative financial statements and accompanying management’s discussion and analysis for the year ended March 31, 2021 (the “Restated Financial Statements“) and the filing of its annual financial statements for the year ended March 31, 2022 along with its associated management’s discussion and analysis and related officer certifications (the “Annual Filings“). The Restated Financial Statements and the Annual Filings are available under the Company’s SEDAR profile at www.sedar.com. Highlights...

ER Fitch Pty Ltd Acquires Securities of Class 1 Nickel & Technologies Limited

Written by Customer Service on December 24, 2022. Posted in Mergers And Acquisitions.

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) — ER Fitch Pty Ltd. ATF Eloise Fitch Family Trust (the “Acquirer”) announces that it has acquired ownership and control of convertible debentures (the “Debentures”) of Class 1 Nickel & Technologies Limited (the “Company” or “Class 1”), effective December 23, 2022 (the “Acquisition”). The Debentures are convertible in accordance with the terms thereof into up to 4,545,454 common shares of the Company (the “Underlying Shares“) at a deemed price of $0.11 per share. The Underlying Shares were issued pursuant to a private placement by the Company and represent approximately 3% of all issued and outstanding common shares of the Company (“Shares”) as of December 23, 2022 on a partially...

Medivolve Announces CAN $1.2 Million Convertible Note Financing

Written by Customer Service on December 24, 2022. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; FRA:4NC), a healthcare technology and services company, today announced a secured convertible note financing in the amount of CAN $1.2 million, which includes a CAN $200,000 original issue discount (“OID”). CAN $1.2 Million Secured Convertible Note This investment will be in the form of a secured convertible note (the “Note”) with a face value of CAN $1.4 million, for aggregate gross proceeds to the Company of CAN $1.2 million after deduction of the OID. Cumulative interest on the outstanding principal amount shall be payable at the annual rate of 8.0% per annum. The Note is expected to mature on December 31, 2023 and will be convertible,...

Day: December 24, 2022